Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 44 Prostatic Neoplasms, Castration-Resistant 6 Neoplasm Metastasis 5 Metastatic Castration-resistant Prostate Cancer 4 Breast Neoplasms 4 Prostate Carcinoma Metastatic to the Bone 2 Neoplasms 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer (mCRPC) 2 Hormone Refractory Prostate Cancer 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bone Metastatic Castration-resistant Prostate Cancer 2 Thyroid Neoplasms 1 Prostate Cancer Metastatic to Bone 1 Prostate Adenocarcinoma 1 Pain 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Fractures, Bone 1 Fatigue 1 Castration-resistant Prostate Cancer 1 Castrate-Resistant Prostate Cancer 1 Bony Metastases From Castrate Refractory Prostate Cancer 1 Bone Neoplasms 1 Bone Metastases 1 Bone Diseases 1 Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Iodine-131 21 lenvatinib 17 Magnetic Resonance Spectroscopy 17 trametinib 13 Sorafenib 13 Thyrotropin Alfa 12 pembrolizumab 11 dabrafenib 11 Thyroidectomy 10 Surgical Procedures, Operative 10 Thyroxine 9 Paclitaxel 9 vandetanib 8 selpercatinib 8 Sunitinib 7 Nivolumab 7 Fluorodeoxyglucose F18 7 cabozantinib 6 anlotinib 6 Everolimus 6 Biopsy 6 pazopanib 5 Vemurafenib 5 Triiodothyronine 5 Specimen Handling 5 Saline Solution 5 Radiotherapy 5 Radiofrequency Ablation 5 Iodine-124 5 Cyclophosphamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × radium Ra 223 dichloride × Clear all

NCT02390934 2019-06-11

RAD-THYR

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Completed

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡